Acadia Pharmaceuticals (NASDAQ: ACAD) Share Price and News

$26.59 $0.71 (2.7%) 5 December 2025 at 7:58:58 am AEDT

Acadia Pharmaceuticals Chart and Price Data

About Acadia Pharmaceuticals

Last updated 05-12-2025, 07:58:58am AEDT
Current Price $26.59
Change $0.71 (2.7%)
Close Price $26.59
Open Price $25.59
Bid $26.58
Ask $26.61
Day Range $25.40 - $26.74
Year Range $13.40 - $26.76
Volume 54,764
Average Volume 1,955,358
Market Cap $4,491,782,100.00
Earnings Per Share $1.55
  • Acadia Pharmaceuticals (NASDAQ: ACAD)
    Latest News

    A woman presenting company news to investors looks back at the camera and smiles.
    Small Cap Shares

    These ASX small cap shares could be tomorrow's blue chips

    Analysts think these small caps could be great picks right now.

    Read more »

    Shot of a senior scientist looking stressed out while working in a lab.
    Healthcare Shares

    Why did this $1.4 billion ASX 200 healthcare stock just dive 9%?

    The market didn't like what this stock had to say this morning...

    Read more »

    Happy shareholders clap and smile as they listen to a company earnings report.
    Share Gainers

    Why Brainchip, Cooper Energy, Core Lithium, and Neuren shares are roaring higher today

    These shares are having a good time on hump day. But why?

    Read more »

    Successful group of people applauding in a business meeting and looking very happy.
    Share Gainers

    2 ASX 200 shares rising on big news

    What's getting investors excited today? Let's find out.

    Read more »

    A young boy sits on his father's shoulders as they flex their muscles at sunrise on a beach
    Investing Strategies

    $10k of savings? I'd buy these ASX 200 shares to grow my money

    I would choose the stocks based on whether the company seems likely to be doing better in five years' time…

    Read more »

    Shot of a senior scientist looking stressed out while working in a lab.
    Healthcare Shares

    This ASX 200 healthcare share is diving 13% as short sellers take aim

    A short seller is describing this company's Daybue product as a 'flop'.

    Read more »

    A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
    Share Gainers

    Why Core Lithium, Neuren, Norwest, and Pilbara Minerals shares are pushing higher

    These ASX shares are defying the market weakness and launching higher.

    Read more »

    A young female ASX investor sits at her desk with her fists raised in excitement as she reads about rising ASX share prices on her laptop.
    Record Highs

    2 ASX 300 shares cracking record highs on Friday

    These ASX 300 shares have ignore recent market volatility and raced to record highs.

    Read more »

    Profile

    since

    Note